Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration

Abstract excerpt

The development of drug resistance in tumors is a major obstacle to effective cancer chemotherapy and represents one of the most significant complications to improving long-term patient outcomes. Despite early positive responsiveness to platinum-based chemotherapy, the majority of lung cancer patients develop resistance. The development of a new combination therapy targeting cisplatin-resistant (CR) tumors may...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chemotherapy-induced organ toxicity mitigation
• Share to DNA Repair Mechanisms
• Share to Genomics, phytochemicals, and oxidative stress